Overview
Universal Health Services, Inc., based in the United States, operates as a prominent health care management company within the healthcare sector. Its primary industry activities focus on providing acute care hospital services and administering behavioral health care facilities. The company is engaged in the development and management of hospitals across the U.S. and the UK, encompassing over 350 facilities. Key projects typically involve the expansion of its hospital network, implementation of advanced medical technologies, and enhancing health care service offerings. Leadership strategies also emphasize regulatory compliance and improving patient outcomes, which align with the industry's shift towards value-based care paradig- ensuring sustainability and growth in the evolving healthcare landscape.
Basic Stats
The share price of Universal Health Services, Inc. - Depositary Receipt (Common Stock) as of September 5, 2025 is R$255.00 / share. This is a decrease of -0.89% from the prior week. The market cap (or net worth) of Universal Health Services, Inc. - Depositary Receipt (Common Stock) as of September 5, 2025 is R$16,410.78 MM.
The Factor Analysis chart (below right) shows a view of Universal Health Services, Inc. - Depositary Receipt (Common Stock) from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 16,410.78 MM |
| EV | |
| Shares Out. | 64.36 MM |
| Earnings Date | |
| EPS (TTM) | 19.59 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -15.04 % |
| Volatility (1 yr) | 0.30 |
| Beta | -0.33 |
| Sharpe Ratio (1 yr) | -0.65 |
| Sortino Ratio (1 yr) | -0.90 |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.09 |
| ROE | 0.19 |
| ROIC | 0.10 |
| CROIC | 0.00 |
| OCROIC | 0.16 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 75.25 /100 |
| Profitability | 70.39 /100 |
| Quality Score | 72.79 /100 |
| Value Score | |
| Momentum Score | 54.70 /100 |
| Stability (Low Vol) Score | 73.39 /100 |
| Analyst Sentiment | 57.71 /100 |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Universal Health Services, Inc. - Depositary Receipt (Common Stock) is R$305.34. The forecasts range from a low of R$228.95 to a high of R$403.91. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Universal Health Services, Inc. - Depositary Receipt (Common Stock). An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2022-05-13 | SVB Leerink | Market Perform | Maintains | |
| 2022-05-03 | Mizuho | Buy | Maintains | |
| 2022-04-28 | Wells Fargo | Underweight | Maintains | |
| 2022-04-27 | Stephens & Co. | Equal-Weight | Maintains | |
| 2022-04-27 | RBC Capital | Sector Perform | Maintains | |
| 2022-04-27 | Credit Suisse | Outperform | Maintains | |
| 2022-03-29 | Wells Fargo | Underweight | Initiate | |
| 2022-03-07 | UBS | Sell | Maintains | |
| 2022-03-03 | Mizuho | Buy | Maintains | |
| 2022-02-28 | Seaport Global | Buy | Neutral | Downgrade |
| 2022-02-28 | SVB Leerink | Market Perform | Maintains | |
| 2022-01-07 | SVB Leerink | Market Perform | Maintains | |
| 2021-12-21 | Barclays | Underweight | Maintains | |
| 2021-10-29 | Mizuho | Buy | Maintains | |
| 2021-10-27 | SVB Leerink | Market Perform | Maintains | |
| 2021-09-27 | SVB Leerink | Market Perform | Initiate | |
| 2021-09-24 | UBS | Sell | Initiate | |
| 2021-09-08 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2021-08-12 | Barclays | Overweight | Underweight | Downgrade |
| 2021-07-28 | Deutsche Bank | Buy | Maintains | |
| 2021-07-27 | Barclays | Overweight | Maintains | |
| 2021-07-09 | Seaport Global | Buy | Initiate | |
| 2021-06-10 | RBC Capital | Outperform | Sector Perform | Downgrade |
| 2021-04-28 | RBC Capital | Outperform | Maintains | |
| 2021-04-19 | Deutsche Bank | Buy | Maintains | |
| 2021-01-05 | B of A Securities | Neutral | Underperform | Downgrade |
| 2020-09-21 | JP Morgan | Neutral | Underweight | Downgrade |
| 2020-07-29 | Credit Suisse | Outperform | Maintains | |
| 2020-07-29 | Piper Sandler | Neutral | Maintains | |
| 2020-06-09 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2020-04-30 | UBS | Buy | Maintains | |
| 2020-04-29 | Deutsche Bank | Buy | Maintains | |
| 2020-04-28 | Citigroup | Buy | Maintains | |
| 2020-04-23 | Piper Sandler | Neutral | Maintains | |
| 2020-03-23 | B of A Securities | Buy | Neutral | Downgrade |
| 2020-03-02 | JP Morgan | Neutral | Maintains | |
| 2020-02-28 | Baird | Outperform | Maintains | |
| 2020-02-28 | UBS | Buy | Maintains | |
| 2020-02-28 | Stephens & Co. | Equal-Weight | Maintains | |
| 2019-12-20 | JP Morgan | Neutral | Maintains | |
| 2019-10-28 | Barclays | Equal-Weight | Maintains | |
| 2019-07-31 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-04-17 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2019-03-04 | UBS | Buy | Buy | Maintains |
| 2019-03-04 | JP Morgan | Overweight | Neutral | Downgrade |
| 2019-03-01 | Wells Fargo | Outperform | Outperform | Maintains |
| 2019-03-01 | Citigroup | Buy | Buy | Maintains |
| 2019-03-01 | Deutsche Bank | Buy | Buy | Maintains |
| 2019-03-01 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2019-02-28 | Baird | Outperform | Outperform | Maintains |
| 2019-01-14 | Stephens & Co. | Equal-Weight | Initiate | |
| 2019-01-03 | Deutsche Bank | Buy | Initiate | |
| 2018-12-14 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2018-10-29 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-10-29 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2018-10-29 | Citigroup | Buy | Buy | Maintains |
| 2018-09-18 | Bank of America | Neutral | Buy | Upgrade |
| 2018-09-05 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-08-14 | Barclays | Equal-Weight | Initiate | |
| 2018-08-01 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2018-07-27 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-07-18 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2018-04-27 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-03-06 | Deutsche Bank | Buy | Buy | Maintains |
| 2018-03-05 | Credit Suisse | Outperform | Outperform | Maintains |
| 2018-03-02 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-03-02 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-01-03 | PiperJaffray | Overweight | Neutral | Downgrade |
| 2018-01-03 | Goldman Sachs | Buy | Initiate | |
| 2017-12-12 | Citigroup | Neutral | Buy | Upgrade |
| 2017-11-10 | Credit Suisse | Outperform | Maintains | |
| 2017-11-02 | Credit Suisse | Outperform | Initiate | |
| 2017-10-27 | Citigroup | Neutral | Maintains | |
| 2017-10-17 | BMO Capital | Outperform | Initiate | |
| 2017-10-11 | Stephens & Co. | Equal-Weight | Initiate | |
| 2017-09-22 | Leerink Swann | Outperform | Maintains | |
| 2017-08-17 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-07-26 | Citigroup | Neutral | Maintains | |
| 2017-06-07 | Morgan Stanley | Equal-Weight | Initiate | |
| 2017-04-05 | Deutsche Bank | Buy | Initiate | |
| 2017-03-27 | Mizuho | Neutral | Buy | Upgrade |
| 2017-03-06 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2017-01-04 | PiperJaffray | Neutral | Initiate | |
| 2016-12-14 | Raymond James | Outperform | Market Perform | Downgrade |
| 2016-11-09 | Avondale Partners | Market Outperform | Market Perform | Downgrade |
| 2016-11-09 | Bank of America | Buy | Neutral | Downgrade |
| 2016-10-24 | Wolfe Research | Peer Perform | Initiate | |
| 2016-09-30 | Citigroup | Neutral | Maintains | |
| 2016-07-29 | JP Morgan | Overweight | Maintains | |
| 2016-07-28 | Barclays | Equal-Weight | Maintains | |
| 2016-03-29 | Wells Fargo | Market Perform | Outperform | Upgrade |
| 2016-03-02 | Sterne Agee CRT | Underperform | Neutral | Upgrade |
| 2016-02-10 | Standpoint Research | Hold | Buy | Upgrade |
| 2015-12-16 | Credit Suisse | Neutral | Initiate | |
| 2015-10-29 | Barclays | Equal-Weight | Maintains | |
| 2015-10-08 | Barclays | Equal-Weight | Maintains | |
| 2015-10-01 | KeyBanc | Sector Weight | Overweight | Upgrade |
| 2015-08-03 | Barclays | Equal-Weight | Maintains | |
| 2015-06-10 | Janney Capital | Neutral | Initiate | |
| 2015-06-05 | Goldman Sachs | Neutral | Initiate | |
| 2015-04-29 | Leerink Swann | Outperform | Maintains | |
| 2015-04-29 | Barclays | Equal-Weight | Maintains | |
| 2015-04-01 | Sterne Agee | Neutral | Underperform | Downgrade |
| 2015-03-02 | Citigroup | Buy | Maintains | |
| 2015-01-08 | Credit Suisse | Outperform | Maintains | |
| 2015-01-08 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2014-12-18 | Sterne Agee | Neutral | Initiate | |
| 2014-10-29 | Barclays | Overweight | Maintains | |
| 2014-10-28 | Barclays | Overweight | Maintains | |
| 2014-09-29 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2014-09-09 | Deutsche Bank | Buy | Maintains | |
| 2014-07-28 | Citigroup | Buy | Maintains | |
| 2014-07-28 | Barclays | Overweight | Maintains | |
| 2014-07-25 | UBS | Buy | Maintains | |
| 2014-07-25 | Credit Suisse | Outperform | Maintains | |
| 2014-07-24 | Deutsche Bank | Buy | Maintains | |
| 2014-06-26 | KeyBanc | Buy | Maintains | |
| 2014-06-03 | JP Morgan | Overweight | Maintains | |
| 2014-06-03 | Avondale Partners | Market Perform | Market Outperform | Upgrade |
| 2014-04-28 | FBR Capital | Outperform | Maintains | |
| 2014-03-31 | Monness Crespi Hardt | Neutral | Initiate | |
| 2013-12-16 | Bank of America | Buy | Maintains | |
| 2013-11-21 | Citigroup | Buy | Maintains | |
| 2013-10-31 | BMO Capital | Market Perform | Maintains | |
| 2013-10-08 | Goldman Sachs | Buy | Initiate | |
| 2013-10-07 | Deutsche Bank | Buy | Maintains | |
| 2013-08-14 | Deutsche Bank | Buy | Maintains | |
| 2013-07-11 | KeyBanc | Hold | Initiate | |
| 2013-05-30 | Deutsche Bank | Buy | Maintains | |
| 2013-05-17 | Susquehanna | Positive | Neutral | Downgrade |
| 2013-04-29 | UBS | Buy | Maintains | |
| 2013-04-29 | BMO Capital | Market Perform | Maintains | |
| 2013-03-25 | JP Morgan | Overweight | Maintains | |
| 2013-03-06 | Citigroup | Buy | Maintains | |
| 2013-03-04 | BMO Capital | Market Perform | Maintains | |
| 2013-03-04 | Wallachbeth | Buy | Hold | Downgrade |
| 2013-03-01 | Credit Suisse | Outperform | Maintains | |
| 2013-01-30 | Deutsche Bank | Buy | Maintains | |
| 2013-01-18 | Standpoint Research | Buy | Hold | Downgrade |
| 2013-01-07 | Susquehanna | Neutral | Positive | Upgrade |
| 2012-12-18 | JP Morgan | Overweight | Initiate | |
| 2012-11-01 | UBS | Neutral | Maintains | |
| 2012-11-01 | Barclays | Overweight | Maintains | |
| 2012-11-01 | BMO Capital | Outperform | Maintains | |
| 2012-11-01 | Credit Suisse | Outperform | Maintains | |
| 2012-11-01 | Deutsche Bank | Buy | Maintains | |
| 2012-10-11 | Barclays | Overweight | Initiate | |
| 2012-10-11 | Bank of America | Buy | Maintains | |
| 2012-09-24 | Standpoint Research | Buy | Initiate | |
| 2012-09-13 | Imperial Capital | Outperform | Initiate | |
| 2012-04-27 | Jefferies | Hold | Maintains | |
| 2012-02-28 | Auriga | Buy | Maintains | |
| 2024-07-10 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-10 | Cantor Fitzgerald | Underweight | Underweight | Reiterate |
| 2024-07-09 | Cantor Fitzgerald | Underweight | Underweight | Reiterate |
| 2024-07-02 | Cantor Fitzgerald | Underweight | Underweight | Reiterate |
| 2024-06-26 | Baird | Neutral | Outperform | Upgrade |
| 2024-05-30 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-05-30 | Baird | Neutral | Initiate | |
| 2024-05-20 | UBS | Neutral | Buy | Upgrade |
| 2024-05-07 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-04-30 | TD Cowen | Hold | Hold | Maintains |
| 2024-04-26 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-04-25 | Stephens & Co. | Equal-Weight | Equal-Weight | Reiterate |
| 2024-04-12 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-04-10 | Cantor Fitzgerald | Underweight | Underweight | Reiterate |
| 2024-03-28 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-03-13 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-03-12 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-03-06 | Mizuho | Buy | Buy | Maintains |
| 2024-03-06 | Barclays | Equal-Weight | Initiate | |
| 2024-03-05 | Cantor Fitzgerald | Underweight | Underweight | Reiterate |
| 2024-03-04 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-03-01 | TD Cowen | Market Perform | Market Perform | Maintains |
| 2024-02-29 | Citigroup | Buy | Buy | Maintains |
| 2024-02-29 | Cantor Fitzgerald | Underweight | Underweight | Maintains |
| 2024-02-29 | UBS | Neutral | Neutral | Maintains |
| 2024-01-02 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2023-12-11 | Goldman Sachs | Sell | Buy | Upgrade |
| 2023-11-17 | JP Morgan | Neutral | Neutral | Maintains |
| 2023-10-20 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2023-09-21 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2023-09-14 | Cantor Fitzgerald | Underweight | Underweight | Reiterate |
| 2023-07-27 | Credit Suisse | Outperform | Outperform | Maintains |
| 2023-07-26 | Stephens & Co. | Equal-Weight | Equal-Weight | Reiterate |
| 2023-07-11 | Mizuho | Buy | Buy | Maintains |
| 2023-05-16 | Goldman Sachs | Sell | Sell | Maintains |
| 2023-05-16 | Mizuho | Buy | Buy | Maintains |
| 2023-05-08 | TD Cowen | Market Perform | Maintains | |
| 2023-04-27 | Citigroup | Buy | Maintains | |
| 2023-04-27 | RBC Capital | Sector Perform | Maintains | |
| 2023-04-27 | Deutsche Bank | Buy | Maintains | |
| 2023-04-27 | Stephens & Co. | Equal-Weight | Maintains | |
| 2023-04-27 | Credit Suisse | Outperform | Maintains | |
| 2023-04-25 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2023-04-21 | Cantor Fitzgerald | Underweight | Initiate | |
| 2023-04-19 | JP Morgan | Neutral | Initiate | |
| 2023-03-06 | Deutsche Bank | Buy | Maintains | |
| 2023-03-06 | Mizuho | Buy | Maintains | |
| 2023-03-06 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-03-03 | Credit Suisse | Outperform | Maintains | |
| 2023-03-01 | RBC Capital | Sector Perform | Maintains | |
| 2023-03-01 | Stephens & Co. | Equal-Weight | Maintains | |
| 2023-03-01 | Wolfe Research | Outperform | Peer Perform | Downgrade |
| 2023-02-28 | Stephens & Co. | Equal-Weight | Reiterate | |
| 2023-01-24 | UBS | Sell | Neutral | Upgrade |
| 2023-01-09 | Barclays | Underweight | Maintains | |
| 2023-01-03 | Wells Fargo | Underweight | Equal-Weight | Upgrade |
| 2022-12-16 | B of A Securities | Underperform | Neutral | Upgrade |
| 2022-12-14 | Mizuho | Buy | Maintains | |
| 2022-11-25 | Credit Suisse | Outperform | Maintains | |
| 2022-11-02 | Mizuho | Buy | Maintains | |
| 2022-10-27 | SVB Leerink | Market Perform | Maintains | |
| 2022-08-24 | SVB Leerink | Market Perform | Maintains | |
| 2022-07-28 | SVB Leerink | Market Perform | Maintains | |
| 2022-07-27 | RBC Capital | Sector Perform | Maintains | |
| 2022-07-15 | SVB Leerink | Market Perform | Maintains | |
| 2022-07-12 | Goldman Sachs | Sell | Maintains | |
| 2022-07-06 | BMO Capital | Market Perform | Underperform | Downgrade |
| 2022-07-01 | Mizuho | Buy | Maintains | |
| 2022-07-01 | Credit Suisse | Outperform | Maintains | |
| 2022-06-30 | SVB Leerink | Market Perform | Maintains | |
| 2022-06-17 | Loop Capital | Hold | Initiate | |
| 2024-11-26 | TD Cowen | Buy | Buy | Maintains |
| 2025-02-28 | Stephens & Co. | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-28 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-10-28 | TD Cowen | Buy | Buy | Maintains |
| 2024-07-26 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2024-07-26 | Cantor Fitzgerald | Underweight | Neutral | Upgrade |
| 2024-07-26 | TD Cowen | Hold | Hold | Maintains |
| 2024-08-14 | UBS | Buy | Buy | Maintains |
| 2024-07-30 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-07-30 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-10-01 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-11-25 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-10-11 | Keybanc | Sector Weight | Initiate | |
| 2025-02-27 | Stephens & Co. | Equal-Weight | Equal-Weight | Reiterate |
| 2025-02-27 | Barclays | Overweight | Overweight | Maintains |
| 2025-04-29 | Barclays | Overweight | Overweight | Maintains |
| 2024-10-16 | TD Cowen | Hold | Buy | Upgrade |
| 2024-10-25 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-10-25 | Barclays | Overweight | Overweight | Maintains |
| 2024-11-06 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-09-04 | Baird | Outperform | Outperform | Maintains |
| 2024-10-22 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-07-25 | Cantor Fitzgerald | Underweight | Underweight | Reiterate |
| 2024-07-25 | Stephens & Co. | Equal-Weight | Equal-Weight | Reiterate |
| 2025-08-26 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2025-04-15 | Baird | Outperform | Neutral | Downgrade |
| 2024-10-04 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-08-19 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-09-09 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2025-03-10 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-08-04 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-08-20 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2025-03-26 | Morgan Stanley | Equal-Weight | Initiate | |
| 2025-07-16 | B of A Securities | Neutral | Underperform | Downgrade |
| 2025-04-30 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2025-04-09 | Guggenheim | Buy | Initiate | |
| 2025-07-30 | Barclays | Overweight | Overweight | Maintains |
| 2025-08-14 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-08-14 | Baird | Neutral | Neutral | Maintains |
| 2025-08-19 | RBC Capital | Sector Perform | Sector Perform | Maintains |
